Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DTPA-bisamide-based MR sensor agents for peroxidase imaging.

Manuel Querol1, John W Chen, Ralph Weissleder

  • 1Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Building 149, 13th Street, Charlestown, Massachusetts 02129, USA.

Organic Letters
|April 23, 2005
PubMed
Summary

Researchers developed new diethylenetriaminepentaacetic acid (DTPA)-bisamides as enzyme-activated contrast agents for MRI. These agents enhance longitudinal relaxivity through in situ oligomerization, improving imaging capabilities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating Extracellular Vesicles Reflect Dynamic Shifts in Liver Transcriptome Following Tumour Resection.

Cancers·2026
Same author

Surgical Removal of Residual Tumor Masses in Patients Undergoing Targeted Therapy for EGFR-Mutated Locally Advanced or Metastatic Lung Cancer.

International journal of cancer·2026
Same author

Deciphering and Targeting the Schwannoma-Neuron-Macrophage Crosstalk for the Treatment of Schwannomatosis and Associated Pain.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Case 2-2026: A 63-Year-Old Man with Pulmonary Nodules, Liver Mass, and Vision Loss.

The New England journal of medicine·2026
Same author

AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1.

Molecular therapy. Methods & clinical development·2025
Same author

Baseline Radiomics as a Prognostic Tool for Clinical Benefit from Immune Checkpoint Inhibition in Inoperable NSCLC Without Activating Mutations.

Cancers·2025

Area of Science:

  • Biomedical Imaging
  • Organic Chemistry
  • Radiochemistry

Background:

  • Magnetic resonance imaging (MRI) requires contrast agents (CA) to enhance image quality.
  • Developing novel CAs with improved relaxivity is crucial for advanced diagnostic applications.

Purpose of the Study:

  • To synthesize and characterize two novel DTPA-bisamide derivatives.
  • To evaluate their potential as enzyme-activated contrast agents for MRI.

Main Methods:

  • Synthesis of DTPA-bisamide derivatives featuring tyramido or 5-hydroxytryptamido groups.
  • In situ oligomerization of derivatives using a peroxidase/H(2)O(2) system.
  • Measurement of longitudinal (R1) relaxivity changes.

Main Results:

Related Experiment Videos

  • Successful synthesis of two novel DTPA-bisamide compounds.
  • Demonstrated in situ oligomerization capability in the presence of peroxidase.
  • Observed a significant increase in longitudinal relaxivity upon oligomerization.

Conclusions:

  • The novel DTPA-bisamide derivatives show promise as enzyme-activated MRI contrast agents.
  • In situ oligomerization is an effective strategy to enhance CA relaxivity.
  • These agents could lead to improved MRI diagnostic sensitivity.